MedPath

WO-533

Generic Name
WO-533

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Phase 2
Completed
Conditions
Vulvovaginal Atrophy
Interventions
First Posted Date
2020-01-10
Last Posted Date
2021-12-23
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Target Recruit Count
43
Registration Number
NCT04222647
Locations
🇩🇪

proDERM Institute for Applied Dermatological Research, Schenefeld, Germany

© Copyright 2025. All Rights Reserved by MedPath